Enzymatically Modified Low-Density Lipoprotein Is Recognized by C1q and Activates the Classical Complement Pathway
Author(s) -
Gérard J. Arlaud,
Adrienn Bı́ró,
Wai Li Ling
Publication year - 2011
Publication title -
journal of lipids
Language(s) - English
Resource type - Journals
eISSN - 2090-3030
pISSN - 2090-3049
DOI - 10.1155/2011/376092
Subject(s) - complement system , classical complement pathway , complement (music) , protein subunit , protease , biochemistry , lipoprotein , chemistry , cholesterol , enzyme , biology , microbiology and biotechnology , antibody , immunology , gene , complementation , phenotype
Several studies suggest that the complement system is involved in atherogenesis. To further investigate this question, we have studied the ability of native and modified forms of LDL to bind and activate C1, the complex protease that triggers the classical pathway of complement. Unlike native LDL, oxidized (oxLDL) and enzymatically modified (E-LDL) derivatives were both recognized by the C1q subunit of C1, but only E-LDL particles, obtained by sequential treatment with a protease and then with cholesterol esterase, had the ability to trigger C1 activation. Further investigations revealed that C1q recognizes a lipid component of E-LDL. Several approaches, including reconstitution of model lipid vesicles, cosedimentation, and electron microscopy analyses, provided evidence that C1 binding to E-LDL particles is mediated by the C1q globular domain, which senses unesterified fatty acids generated by cholesterol esterase. The potential implications of these findings in atherogenesis are discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom